Stocktoria
CytoDyn Inc. CYDY
OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2005-11-17
CytoDyn Inc. statistics & valuation
Market cap$339.7M
P / E90.7×
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | 80.1% | — | — | — | — | — | — |
| Operating margin | — | — | — | -54663.2% | — | — | — | — | — | — |
| Net margin | — | — | — | -79255.6% | — | — | — | — | — | — |
| Return on assets | 20.8% | -447.6% | -706.9% | -722.4% | -133.6% | -277.0% | -290.9% | -1023.7% | -319.8% | -186.4% |
| Return on equity | -3.9% | 42.7% | 72.9% | 223.3% | 839.6% | 5640.3% | 681.2% | 381.1% | 2335.3% | -251.9% |
| Debt / equity | -0.47× | -0.39× | -0.42× | -0.45× | -2.01× | — | — | -0.00× | — | — |
| Current ratio | 0.25 | 0.13 | 0.09 | 0.09 | 0.24 | 0.83 | 0.20 | 0.20 | 1.00 | 3.21 |
Source: SEC EDGAR filings · CIK 0001175680 · as of 2025-05-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.